Signed malware backed by a stolen EV certificate deployed legitimate RMM tools to gain persistent access inside enterprise ...

The Food and Drug Administration reversed course on Wednesday and agreed to formally review Moderna’s new flu vaccine that uses mRNA technology, the company announced in a news release. Earlier this ...

Moderna said on Wednesday the U.S. drug regulator will review its modified flu vaccine application, a week after rejecting the original submission and fueling industry concerns over shifts in the ...

Moderna said Wednesday the Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the original submission and fueling ...

Moderna's shares close up 6% Moderna to conduct post-marketing study in older adults FDA decision expected by August 5 Feb 18 (Reuters) - Moderna said on Wednesday the U.S. Food and Drug ...

Moderna said on Wednesday (February 18) the U.S. drug regulator will review its modified flu vaccine application, a week after rejecting the original submission and fueling industry concerns over ...

Add Yahoo as a preferred source to see more of our stories on Google. In December 2025, Moderna submitted an application to the FDA to approve the first mRNA-based flu vaccine. Catherine Falls ...

Ana Santos Rutschman does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

The Food and Drug Administration has refused to review an application from the biotech company Moderna to approve its mRNA-based flu vaccine. The agency's decision, which Moderna announced in a press ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Ana Santos Rutschman, Villanova University (THE CONVERSATION) The Food and Drug ...